Related Experiment Video
Updated: Jan 9, 2026

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Pott's puffy tumor in the post-COVID era
Siegfried J Adelhoefer1, Eric M Jackson2, Mari Groves2
1Division of Pediatric Neurosurgery, Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, USA. jason.adelhoefer@gmail.com.
Pott's puffy tumor (PPT) is a serious complication of frontal sinusitis. Early surgery and antibiotics led to a 92% full recovery rate in a recent US cohort.
Area of Science:
- Neurology
- Otolaryngology
- Infectious Disease
Background:
- Pott's puffy tumor (PPT) is an intracranial complication of frontal sinusitis, potentially causing severe neurological issues.
- Symptoms include headache, periorbital swelling, and in some cases, seizures or thrombosis.
- While historically linked to sinusitis, an increase in PPT cases has been noted post-COVID-19.
Purpose of the Study:
- To analyze the demographics, clinical presentation, and outcomes of patients with Pott's puffy tumor.
- To investigate potential links between PPT and COVID-19.
- To contribute data on the largest reported PPT cohort in the USA.
Main Methods:
- Retrospective review of 24 patients treated at a major US tertiary-referral center from 2020 to 2024.
- Data collected included clinical presentation, diagnostic workup, surgical approach, and recovery status.
- Primary outcome was recovery status (full, partial, death).
Main Results:
- 24 patients (17 boys) presented with sinusitis (75%), periorbital swelling (71%), and fever (63%); 33.3% had seizures.
- Most patients underwent bifrontal craniotomy and frontal sinus exenteration.
- 92% achieved full recovery, with one partial recovery and one death (due to unrelated malignancy).
Conclusions:
- Early surgical intervention and broad-spectrum antibiotics are crucial for treating Pott's puffy tumor.
- A causal link between COVID-19 and PPT was not identified in this cohort.
- Increased PPT awareness is vital for optimal patient care in the post-COVID era.
Related Concept Videos
Pneumonia II: Pathophysiology
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

